Currently there are two preferred brands of rescue inhaler for commercial and
Medicare Part D members, including ProAir HFA.
Effective October 1, 2013, IBC will designate ProAir HFA as our only preferred
brand of rescue inhaler for commercial members. Medicare Part D members will
not be affected by this change.
Commercial members who are currently prescribed a rescue inhaler will be mailed
a letter this month notifying them of this change. The letter will explain that
in order for other brands of rescue inhaler to be covered, prior authorization
will be required and, in some cases, members will pay a higher level of
cost-sharing.
Prescribing options for commercial members as of October 1, 2013:
Prescribe ProAir HFA. ProAir HFA will continue to be covered at the brand
formulary level of cost-sharing. Prior authorization will not be required.
Prescribe a non-preferred rescue inhaler (i.e., other than ProAir HFA). You
will need to submit to FutureScripts
® a prior authorization
request using the
General Pharmacy form, which is located on the
FutureScripts website. In
some cases, members who are prescribed a non-preferred rescue inhaler will be
responsible for the highest nonformulary level of cost-sharing.
If ProAir HFA is not prescribed, we strongly recommend that you allow
additional time for us to process the prior authorization request when writing
a new prescription.
If you have any questions, please contact FutureScripts at 1-888-678-7012.
FutureScripts® and
FutureScripts® Secure are independent companies that provide
pharmacy benefits management services.